Eke I, Schneider L, Krause M, Baumann M, Förster C, Ingargiola M, Kunz-Schughart LA, Cordes N (2013) JNK2 activation via EGFR-JIP-4 protein complex perturbs Cetuximab-mediated radiosensitization of human squamous cell carcinoma cells. Cancer Res 73: 297-306

Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, Thames HD, Krause M, Baumann M (2013) GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial. Radiother Oncol 106: 229-304

Eke I, Storch K, Krause M, Cordes N (2013) Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis in non-small cell lung cancer, Cancer Res 73: 5869-5879

Koch U, Höhne K, von Neubeck C, Thames HD, Yaromina A, Dahm-Daphi J, Baumann M*, Krause M* (*shared last authorship) (2013) Residual gH2AX foci predict local tumour control after radiotherapy. Radiother Oncol 108: 434-439

Krause M, Kummer B, Deparade A, Eicheler W, Pfitzmann D, Yaromina A, Kunz-Schughart L, Baumann M (2013) Simultaneous PLK1 inhibition improves local tumour control after fractionated irradiation. Radiother Oncol 108: 422-428

Abramyuk A, Appold S, Zöphel K, Baumann M, Abolmaali N (2013) Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy. Strahlenther Onkol 189: 197-201

Baumann M, Budach V, Molls M (2013) Zum Gedenken an Prof. Dr. Kian Ang. Strahlenther Oncol 189: 907

Baumann M, Bodis S, Dikomey E, van der Kogel A, Overgaard J, Rodemann HP, Wouters B (2013) Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiother Oncol. 108:357-361

Bütof R, Baumann M (2013) Time in radiation oncology - keep it short! Radiother Oncol 106: 271-275.

Bütof R, Dubrovska A, Baumann M (2013) Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 108: 388-396

Cordes N, Gurtner K, Belka C (2013) Verbesserte Behandlungschancen durch molekulares Targenting in der Radioonkologie. Onkologe: 848-857   

Dietrich A, Stewart J, Huether M, Helm M, Schuetze C, Schnittler HJ, Jaffray DA, Kunz-Schughart LA (2013) Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE). Mol Imaging Biol 15: 693-702

Dubois L, Peeters SG, van Kuijk SJ, Yaromina A, Lieuwes NG, Saraya R, Biemans  R, Rami M, Parvathaneni NK, Vullo D, Vooijs M, Supuran CT, Winum JY, Lambin P (2013) Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol 108: 523-528

Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess CF, Berger B, Wiegel T, Rödel C, Niewald M, Hermann RM, Lubgan D (2013) A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer 119: 3343-3353

Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N (2013) Safety and efficacy of stereotactic body radiotherapy for stage i non-small-cell  lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8: 1050-1058

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109: 13-20

Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P (2013) Use of EORTC target definition guidelines for dose-intensified salvage radiation  therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 87: 534-541

Zeil K, Baumann M, Beyreuther E, Burris-Mog T, Cowan TE, Enghardt W, Karsch L, Kraft SD, Laschinsky L, Metzkes J, Naumburger D, Oppelt D, Richter C, Sauerbrey R, Schuerer M, Schramm U, Pawelke J (2013) Dose controlled irradiation of cancer cells with laser accelerated proton pulses. Appl Phys B 110: 437-444

Zips D, Baumann M (2013) Place of proton radiotherapy in future radiotherapy practice. Semin Radiat Oncol 23: 149-153